See how Doris O. Matsui's votes line up with your values.
DeepSyte scores Doris O. Matsui's record on the issues you care about — not party, not press releases. Take the 2-minute values quiz to see your personal alignment.
Sign in and take the values quiz to see how Doris O. Matsui's votes line up with your views.
Prediction track record
How often we called Doris O. Matsui's passage votes correctly, from their stated positions on each bill's tagged topics. Excludes “unclear” calls and abstentions.
To prohibit the disclosure of records by the Secretary of Housing and Urban Development of individuals for the purposes of immigration enforcement, and for other purposes.
A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals.
No paired statements and votes yet for Doris O. Matsui
We haven't yet found statement/vote pairs on the same topic for Doris O. Matsui. This usually means either the rep hasn't taken public positions on bills that have come to a passage vote, or those bills haven't been tagged yet. The checker runs as new press releases and votes come in.
Pro analysis
AI rep analysis — Pro
Get an AI-narrated read on Doris O. Matsui's full voting record against your stated values — aligned themes, conflicts, notable votes, and what to watch for.
We haven't extracted campaign positions for Doris O. Matsui yet. Once their campaign website or position pages are processed, this card will track what they said vs how they voted.
Crossing the aisle
Passage votes where Doris O. Matsui broke ranks with ≥75% of Democrats. Threshold catches substantively partisan splits; unanimous-ish or close votes are excluded.
MATSUI INTRODUCES BIPARTISAN LEGISLATION TO PROTECT PATIENT ACCESS TO AFFORDABLE MEDICATIONS
Position: The release supports the bipartisan PROTECT 340B Act, which would prohibit PBMs and insurers from imposing discriminatory terms on 340B-participating providers, create a centralized process to resolve duplicate discounts, and end the 340B Rebate Model Pilot Program.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (D-CA) and Congressman Tracey Mann (R-KS) introduced the bipartisan Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act, legislation to stop pharmacy benefit managers (PBMs) and health insurers from exploiting the 340B Drug Pricing Program at the expense of patients and safety-net healthcare providers. Additionally, the PROTECT 340B Act creates a third-party clearinghouse for duplicate discounts and ends the 340B Rebate Model Pilot Program.
“The 340B program was created to ensure that patients, hospitals, and health centers have access to discounted medicines, not pad the profits of pharmacy benefit managers and insurance companies,” said Congresswoman Matsui. “When these companies take advantage of 340B, they’re taking resources away from patients who need access to care the most. My bill puts a stop to these unfair practices and protects the care Sacramento families and Americans across the country depend on.”
Last year, the 340B program allowed safety-net hospitals, local health centers, and other eligible entities to purchase $100 billion in discounted outpatient medications, helping them stretch limited resources to serve patients in underserved communities. Yet discriminatory reimbursement rates, fees, and restrictions imposed by PBMs and insurers threaten to divert resources intended for patient care into the pockets of healthcare middlemen. The PROTECT 340B Act would:
Prohibit discriminatory PBM insurer practices: Prevent lower reimbursement rates, unfair fees, restrictive pharmacy network requirements and other discriminatory conditions imposed solely because a provider or pharmacy participates in 340B. The protections would also extend to Medicare Part D and Medicare Advantage.
Strengthen accountability and enforcement: Authorize civil monetary penalties of up to $5,000 per violation per day for PBMs that violate the law.
Prevent Medicaid duplicate accounts: Establish an independent, centralized process to identity and resolve duplicate discounts while protecting confidential claims data and allowing providers to submit information retrospectively.
End the 340B Rebate Model Pilot Program: Require the Department of Health and Human Services (HHS) to terminate the pilot program and prohibit the establishment of a similar program.
“The 340B Drug Pricing Program is an essential tool to not only provide affordable, life-saving medications for struggling Californians, but also to support their healthcare in many other ways,” said Jenny Nguyen, Vice President, Financial Policy, California Hospital Association. “Here in California, 340B has a meaningful and positive impact by helping provide: free health screenings for low-income and unhoused Californians, emergency financial aid for children and families, community health education programs, and much more. Congress should do all it can to preserve the 340B program and the support it provides every day for Californians in need.”
“The 340B program is vital to Community Health Centers (CHCs) and the 52 million people — 1 in 7 Americans, including 1 in 3 in rural communities — who rely on them for affordable, comprehensive and effective care,” saidKyu Rhee, MD, MPP, President and CEO of NACHC. “By ending the rebate model and prohibiting discriminatory actions against covered entities and their pharmacies, the PROTECT 340B Act helps ensure 340B savings stay with the patients they were intended to help and continue to support access to affordable, life-saving medications for the patients we serve. We are grateful to Congresswoman Doris Matsui and Congressman Tracey Mann for their bipartisan leadership on this important legislation. We look forward to working with them and Members of Congress on both sides of the aisle to advance legislation that protects and strengthens the 340B program for CHCs and their patients.”
“We thank Representatives Matsui (D-CA) and Tracey Mann (R-KS) for reintroducing the Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2026,” said Samuel V. Calabrese, MBA, RPh, CPEL, FASHP, Executive Vice President and CEO of ASHP. “The PROTECT 340B Act of 2026 prohibits PBM and insurer discrimination against safety net hospitals and clinics, and creates an independent 3rd party clearing house to oversee the program.”
BACKGROUND
The 340B Drug Pricing Program was enacted by Congress in 1992 with bipartisan support and is overseen by the Health Resources and Services Administration (HRSA) under the Department of Health and Human Services (HHS). The program requires that pharmaceutical companies give safety net and rural healthcare providers discounts on their drugs, in exchange for having their drugs covered by Medicaid.
The program has a demonstrated record of protecting patients who are low-income, live in underserved communities, or suffer from serious chronic illnesses from the threat of skyrocketing prices for the drugs they depend on the most.
For safety-net providers already operating on tight margins, reduction in 340B savings means fewer resources to provide the care Americans depend on. Shifting away from upfront discounts and adding new financial and administrative burdens puts even more pressure on providers, with patients ultimately paying the price. According to a 2025 survey by 340B Health, 92% of responding hospitals said they would have to reduce free or discontinued medications if manufacturers broadly implemented proposed rebate models.
Congresswoman Matsui has long championed improving 340B to ensure its benefits reach the patients and communities Congress intended. In 2025, she introduced the 340B PATIENTS Act to protect access to medications through contract pharmacies and led a bipartisan letter signed by 166 members of Congress opposing the administration’s rebate pilot. She also led a bipartisan effort this year to block federal funding for implementation of the rebate model, warning the shifting away from upfront discounts could place new financial burdens on safety-net providers and threaten patient care.
The PROTECT 340B Act is endorsed by the Association of American Medical Colleges (AAMC), America's Essential Hospitals, American Hospital Association, Children's Hospital Association, National Rural Health Association, American Society of Health-System Pharmacists, California Hospital Association, California Children's Hospital Association, Ascension, National Association of Community Health Centers (NACHC), and National Association of Counties (NACo).
Original cosponsors of the legislation includes Representatives Stephanie Bice (R-OK), Jim Costa (D-CA), Sharice Davids (D-KS), Maggie Goodlander (D-NH), Eleanor Holmes Norton (D-DC), Jonathan L. Jackson (D-IL), Raja Krishnamoorthi (D-IL), Stephen F. Lynch (D-MA), Seth Moulton (D-MA), Debbie Dingell (D-MI), Dan Meuser (R-PA), and Gwen Moore (D-WI).
Full text of the PROTECT 340B Act availableHERE.
Issues:Health Care
MATSUI ACTS TO PROTECT AMERICANS FROM HIGH COSTS AT THE GAS PUMP
Position: The release supports legislation requiring the Department of Transportation to reevaluate fuel economy (CAFE) standards when gas prices rise rapidly and to restore and increase financial penalties on automakers whose fleets fail to meet fuel efficiency standards.
WASHINGTON, D.C. — Today, Congresswoman Doris Matsui (CA-07) introduced legislation to require the Department of Transportation (DOT) to examine whether it can strengthen fuel efficiency requirements to counter high gas prices and reinstate penalties for automakers that fail to produce fuel-efficient vehicles.
“Across the country, Americans are being squeezed by high gas prices, rising grocery bills, and everyday costs that keep stretching family budgets thinner,” said Congresswoman Matsui. “The Gas Money Saved Act meets people where they are by strengthening fuel efficiency standards that help drivers spend less on gas for years to come. This is a practical step to lower everyday costs, give families more breathing room, and build a cleaner, more efficient transportation future.”
“With gas prices skyrocketing because of President Trump’s prolonged and illegal war, we must take immediate steps to give American consumers some relief,” said Congresswoman Titus. “In May 2026, gas prices rose at a rate ten times higher than the rate of inflation. In Nevada, they now average $5.45 per gallon. Coupled with higher prices on groceries and other goods because of the Trump tariffs, families are struggling to make ends meet.”
Congresswoman Matsui, a member of the House Energy and Commerce Committee, and Rep. Dina Titus (NV-01), a member of the House Transportation Committee, introduced the Gas Money Saved Act to review Corporate Fuel Economy (CAFE) standards and reinstate fuel-efficiency requirements that were stripped away by Republicans’ Big Ugly Bill in 2025. Companion legislation has been introduced in the Senate by Senator Ed Markey (D-MA).
“Fuel economy standards help American drivers get around without breaking the bank while gas prices are high, but Trump and the Republicans gutted these standards as part of their crusade to put Big Oil above American families,” said Senator Markey. “Auto innovation should give consumers better choices, not cut corners at their expense. The Gas Money Saved Act would make sure American drivers have fuel-efficient vehicle options that are cheaper to fill up and hold automakers to account—a cost-saving measure that is especially critical as the Trump Administration would rather spend billions on an illegal war than keep costs low for Americans.
The Gas Money Saved Act would:
Require DOT to reevaluate CAFE standards if gas prices rise at a rate five times faster than inflation over a six-month period, and;
Restore and increase financial penalties on automakers if their car and truck fleet does not meet fuel efficiency standards.
Full bill text can be found HERE.
MATSUI, LEADER SCHUMER, MARKEY, MENENDEZ, MENG LEAD COLLEAGES IN DEMANDING TRUMP FCC WITHDRAW PROPOSAL TO UNDERMINE E-RATE PROGRAM
Position: The lawmakers urge FCC Chairman Brendan Carr to withdraw the Commission's proposal to eliminate or limit the E-Rate program, which funds broadband access for schools and libraries. They argue that cutting E-Rate would harm students, libraries, economic competitiveness, and national security, and that it is not an effective child-safety measure.
WASHINGTON, D.C. — Today, Congresswoman Doris Matsui (D-CA), Senate Democratic Leader Chuck Schumer (D-NY), Senator Edward J. Markey (D-Mass.), and Representatives Rob Menendez (D-NJ) and Grace Meng (D-NY), led nearly the entire Senate Democratic Caucus and more than 60 members of the House Democratic Caucus in urging Federal Communications Commission (FCC) Chairman Brendan Carr to withdraw the Commission’s damaging proposal to eliminate or limit the E-Rate program. In June, the Carr FCC voted to open a rulemaking examining E-Rate, which helps schools and libraries across the country afford reliable internet access.
For nearly 30 years, E-Rate has helped close the digital divide by ensuring that students and library patrons can access the internet regardless of their income or ZIP code. In 2025, E-Rate helped more than 158,000 schools and libraries pay recurring broadband bills, increase bandwidth, maintain secure internal Wi-Fi networks, and replace aging infrastructure. Ending or sharply curtailing E-Rate would impose severe costs on schools and libraries while weakening economic growth, undermining American technological leadership, and jeopardizing national security. The E-Rate program has invested more than $69 billion to connect schools and libraries to the internet across the country.
In the letter, the lawmakers wrote, “Schools and libraries help develop the next generation of engineers, scientists, and cybersecurity professionals, including in communities that have historically lacked access to those opportunities. Cutting E-Rate would narrow that talent pipeline. Maintaining connectivity in every school and library is therefore an investment in America’s technological leadership, economic competitiveness, and national security.
The lawmakers continued, “We strongly support measures to protect children online and address concerns around excessive screen time. But cutting E-Rate is not a child-safety measure. E-Rate funds broadband connectivity — not laptops, tablets, applications, or online content — and recipients must already comply with the Children’s Internet Protection Act, including by using filtering and blocking tools, adopting internet-safety policies, and educating students about appropriate online behavior. States and local communities, meanwhile, are developing targeted policies governing when and how students use devices in schools — an appropriate way to address screen-time concerns, rather than cutting broadband support. The Commission should not use child safety as a pretext to dismantle the secure, managed broadband infrastructure that schools and libraries need to educate students and help them navigate the digital world safely.”
Full letter can be found HERE.
The letter was signed by Senators Angela Alsobrooks (D-Md.), Tammy Baldwin (D-Wis.), Michael Bennet (D-Colo.), Richard Blumenthal (D-Conn.), Lisa Blunt Rochester (D-Del.), Cory Booker (D-N.J.), Maria Cantwell (D-Wash.), Chris Coons (D-Del.), Catherine Cortez Masto (D-Nev.), Tammy Duckworth (D-Ill.), Dick Durbin (D-Ill.), John Fetterman (D-Pa.), Ruben Gallego (D-Ariz.), Kirsten Gillibrand (D-N.Y.), Maggie Hassan (D-N.H.), Martin Heinrich (D-N.M.), John Hickenlooper (D-Colo.), Mazie Hirono (D-Hawaii), Tim Kaine (D-Va.), Mark Kelly (D-Ariz.), Andy Kim (D-N.J.), Angus King (I-Maine), Amy Klobuchar (D-Minn.), Ben Ray Luján (D-N.M.), Jeff Merkley (D-Ore.), Chris Murphy (D-Conn.), Patty Murray (D-Wash.), Alex Padilla (D-Calif.), Gary Peters (D-Mich.), Jack Reed (D-R.I.), Jacky Rosen (D-Nev.), Bernie Sanders (I-Vt.), Brian Schatz (D-Hawaii), Adam Schiff (D-Calif.), Chuck Schumer (D-N.Y.), Jeanne Shaheen (D-N.H.), Elissa Slotkin (D-Mich.), Tina Smith (D-Minn.), Chris Van Hollen (D-Md.), Mark Warner (D-Va.), Raphael Warnock (D-Ga.), Elizabeth Warren (D-Mass.), Peter Welch (D-Vt.), Sheldon Whitehouse (D-R.I.), and Ron Wyden (D-Ore.).
The letter was signed by Representatives Gabe Amo (RI-01), Becca Balint (VT-AL), Nanette Barragán (CA-44), Suzanne Bonamici (OR-01), Shontel Brown (OH-11), Nikki Budzinski (IL-13), Troy Carter (LA-02), Kathy Castor (FL-14), Judy Chu (CA-28), Yvette Clarke (NY-09), Emanuel Cleaver (MO-05), Jim Costa (CA-21), Joe Courtney (CT-02), Sharice Davids (KS-03), Don Davis (NC-01), Suzan DelBene (WA-01), Debbie Dingell (MI-06), Lizzie Fletcher (TX-07), Bill Foster (IL-11), John Garamendi (CA-08), Josh Gottheimer (NJ-05), Jahana Hayes (CT-05), Jim Himes (CT-04), Jonathan Jackson (IL-01), Robin Kelly (IL-02), Raja Krishnamoorthi (IL-08), Greg Landsman (OH-01), Summer Lee (PA-12), John Mannion (NY-22), Sarah McBride (DE-AL), April McClain Delaney (MD-06), Jennifer McClellan (VA-04), Betty McCollum (MN-04), Jim McGovern (MA-02), Gwen Moore (WI-04), Seth Moulton (MA-06), Johnny Olszewski, Jr. (MD-02), Ilhan Omar (MN-05), Chris Pappas (NH-01), Scott Peters (CA-50), Chellie Pingree (ME-01), Jamie Raskin (MD-08), Deborah Ross (NC-02), Andrea Salinas (OR-06), Jan Schakowsky (IL-09), Hillary Scholten (MI-03), Darren Soto (FL-09), Greg Stanton (AZ-04), Haley Stevens (MI-11), Marilyn Strickland (WA-10), Suhas Subramanyam (VA-10), Tom Suozzi (NY-03), Bennie Thompson (MS-02), Dina Titus (NV-01), Rashida Tlaib (MI-12), Jill Tokuda (HI-02), Paul Tonko (NY-20), Derek Tran (CA-45), Lauren Underwood (IL-14), Marc Veasey (TX-33), Bonnie Watson Coleman (NJ-12), and Delegate Eleanor Holmes Norton (DC-AL).
Issues:Technology
MATSUI, DEGETTE, BEYER STATEMENT ON ILLEGAL IMPOUNDMENT OF HEALTH RESEARCH FUNDS
Position: The representatives state that the administration illegally impounded $78 million in FY2025 funding for the Agency for Healthcare Research and Quality, in violation of Congress's constitutional power of the purse, and call on Republicans to join in upholding the Constitution.
WASHINGTON, D.C. — Today, Representatives Doris Matsui (CA-07), Diana DeGette (CO-01), and Don Beyer (VA-08) released the following statement after the Government Accountability Office (GAO) issued a legal determination confirming the administration illegally impounded $78 million in Fiscal Year 2025 funding for the Agency for Healthcare Research and Quality (AHRQ). The decision comes more than a year after Reps. Matsui, DeGette, and Beyer sent the initial request for a nonpartisan legal opinion on the matter.
“The GAO’s decision today confirms what we have known for over a year: Donald Trump is stealing taxpayers’ dollars that Congress set aside to improve Americans’ health. The administration’s unilateral dismantling of the Agency for Healthcare Research and Quality’s grantmaking operations is an illegal impoundment of Congressionally appropriated funds.
“Under Article I of the Constitution, the power of the purse rests strictly with Congress, not the executive branch. Trump’s administration cannot simply refuse to spend the resources we authorized for lifesaving health care research. Republicans must join Democrats in demanding that the Constitution is upheld.”
Background:
The Trump administration’s massive cuts at the Department of Health and Human Services beginning April 1, 2025, disrupted grant funding for health care research across the country, including in Colorado. AHRQ suffered particularly devastating impacts to its grants supporting more efficient, effective, and safe health care. Grantmaking at AHRQ halted: from April 1 to September 5, 2025, AHRQ did not issue a single grant. The agency would typically issue up to 73 grants during a comparable time period.
In September 2025, Representatives Matsui, DeGette, and Beyer sent a request to GAO for their legal opinion on whether disruptions of AHRQ’s grantmaking process represented illegal withholding of funds in violation of the Impoundment Control Act, which regulates the president’s ability to delay or withhold Congressionally appropriated spending. The GAO is often called the “Congressional watchdog” for its role in investigating federal government spending and performance.
Today, after a lengthy nonpartisan investigation, the GAO announced its findings that the Trump administration did illegally withhold—or impound—$78 million Congress directed to support healthcare research.
Issues:Health Care
MATSUI, DUCKWORTH, SCHUMER LEAD BIPARTISAN CALL REQUIRING FAA TO GUARANTEE EVERY EMERGENCY MEDICAL KIT ABOARD FLIGHTS INCLUDE LIFE-SAVING EPINEPHRINE
Position: Lawmakers urge the FAA to require that emergency medical kits on all commercial flights include epinephrine in pre-measured, self-administrable delivery devices, and oppose the FAA's proposed rule that would not require such devices.
WASHINGTON D.C. – Today, Congresswoman Doris Matsui (D-CA-07), Co-Chair of the Congressional Food Allergy Research Caucus, U.S. Senator Tammy Duckworth (D-IL),Ranking Member of the U.S. Senate Commerce Subcommittee on Aviation, and U.S. Senate Democratic Leader Chuck Schumer (D-NY) led a group of 20 bipartisan, bicameral lawmakers in calling on the Federal Aviation Administration (FAA) to guarantee that emergency medical kits (EMK) on every commercial aircraft include epinephrine, a life-saving medication to treat passengers who go into anaphylactic shock. Today is the final day for the American people to submit public comments on the FAA’s dangerous new proposed rule that would result in medications being less consistent and dependable for passengers experiencing health emergencies on commercial flights—a severely misguided proposal that prioritizes flexibility for air carriers over the safety of the flying public.
“Without proper medications that can easily be administered on board, medical emergencies happening while 35,000 feet in the air could turn deadly,” wrote the lawmakers in their official public comment to the FAA’s proposed rule. “The provisions outlined in the FAA’s proposed rule threaten the safety of airline passengers traveling with allergies and reverse previous FAA action to ensure the safety of all passengers.”
In the landmark 2024 FAA Reauthorization Law that Congresswoman Matsui supported, the FAA requires commercial airlines to have adequate emergency medical kits on board to treat conditions like anaphylaxis. And yet, the FAA’s proposed rule would not require them to carry epinephrine—the only medication that reliably treats this medical emergency—in delivery methods that can be easily self-administered by individuals without medical training.
The lawmakers continued, “If a passenger is experiencing anaphylaxis, they could have mere seconds until they are unable to breathe. Without FDA-approved epinephrine delivery methods designed to be easily self-administered, passengers rely on the chance that there will be a good Samaritan on the flight who is a trained medical professional, or a flight attendant, in consultation with a medical professional on the ground, to quickly measure an appropriate dose of epinephrine using a vial and syringe. This is both risky and unnecessary; it is why the FAA’s working group recommended ‘pre-measured auto-delivery device’ be on the EMK contents list.”
In their letter, the lawmakers hammered the FAA’s proposed rule for ignoring expert recommendations, creating an even greater lack of transparency and consistency in EMKs for the flying public—who rely on EMKs during a medical emergency—and for needlessly putting the lives of commercial airline passengers at greater risk.
“To ensure the safety of all airline passengers, we must guarantee that U.S.-based airlines include FDA-approved epinephrine delivery methods designed for self-administration on every flight,” the lawmakers concluded.
In light of the FAA’s misguided and dangerous proposed rule change, Matsui, Duckworth, and Schumer are calling on the FAA to heed their concerns—as well as the more than 1,500 public comments that have been submitted to express deep concern over this would-be policy failure that would place cost cutting and convenience for air carriers over the safety of the flying public.
In addition to Matsui, the letter is co-signed in the House by U.S. Representatives Debbie Dingell (D-MI-06), Brian Fitzpatrick (R-PA-01), Maxwell Frost (D-FL-10), Sylvia Garcia (D-TX-29), Josh Gottheimer (D-NJ-05), Raja Krishnamoorthi (D-IL-08), LaMonica McIver (D-NJ-10), Kelly Morrison (D-MN-03) and Mike Quigley (D-IL-05). In addition to Duckworth and Schumer, the letter is co-signed in the Senate by U.S. Senators Tammy Baldwin (D-WI), Richard Blumenthal (D-CT), Cory Booker (D-NJ), Kirsten Gillibrand (D-NY), Andy Kim (D-NJ), Amy Klobuchar (D-MN), Jack Reed (D-RI) and Sheldon Whitehouse (D-RI).
Full text of the letter can be found below and HERE.
Dear Administrator Bedford:
We write to provide our comments on the Federal Aviation Administration (FAA)’s Notice of Proposed Rulemaking (NPRM) published on August 5, 2026, which would make drastic changes to how the FAA determines the composition of the emergency medical kit (EMK) carried aboard aircraft. The proposed rule is opaque and dangerous, and it threatens to undermine previous work the FAA has done to ensure the safety of the traveling public.
EMKs are supposed to enable initial treatment of a passenger experiencing moderate to severe injuries or illnesses until the aircraft can land and the passenger can be transferred to emergency medical personnel. Without proper medications that can easily be administered on board, medical emergencies happening while 35,000 feet in the air could turn deadly.
The proposed rule would make harmful steps to reverse work done at the agency to direct operators to include epinephrine in aircraft EMKs. Having multiple doses of epinephrine on every aircraft, in delivery methods that can be easily self-administered by individuals without medical training, is more urgent than ever. This is due to the on-flight presence of food items containing unlabeled allergens, a steady increase in the number of children with food allergies, the increased prevalence of a tick-borne illness that could create life-threatening allergies and the very real possibility that more than one passenger may require epinephrine during a single flight.
The provisions outlined in the FAA’s proposed rule threaten the safety of airline passengers traveling with allergies and reverse previous FAA action to ensure the safety of all passengers.
Our concerns about the proposed rule are outlined below:
Lack of Alignment with Previous Recommendations
The FAA Reauthorization Act of 2024 directed the FAA to assemble a panel of experts to make recommendations on EMKs and issue a proposed rule. The FAA Onboard Medical Kits Working Group included aerospace medicine experts and physicians, physiologists, psychologists, human factors specialists, cabin safety professionals and researchers. This working group submitted its report, dated May 1, 2025, to the FAA. The report stated:
“The items proposed … are intended to provide initial stabilizing Basic Life Support (BLS) care for immediately life-threatening conditions such as cardiac arrest, airway emergencies, major hemorrhage, andanaphylaxis (emphasis added), as well as to facilitate provision of limited basic first-aid interventions for minor injuries and illnesses that are known to occur in-flight.”
Importantly, the proposed EMK content list in the report includes both “pre-measured auto-delivery device” or “vial-drawn kit.” Yet, just one year later, the FAA publicly defied the recommendations in this report developed by the expert working group the FAA itself commissioned.
No Clear Requirement for Epinephrine
Through rulemaking, the Trump administration is seeking to downgrade the EMK content list, from a binding requirement to mere optional guidance. The proposed rule would allow operators to determine what components should be included in EMKs, so long as the EMK is “practical and sufficient” to address nine conditions, including anaphylaxis:
“…FAA recommends sufficient resources for anaphylaxis (sudden/acute severe allergic reaction), which may include the following signs and symptoms: hives; swelling of the mouth, throat, or tongue; difficulty breathing, rapid or weak pulse, dizziness; stomach pain; nausea or vomiting; or loss of consciousness. Treatment options could (emphasis added) include medication such as epinephrine.”
Epinephrine is the first-line treatment for anaphylaxis. The final rule must contain a clear directive that EMKs shall include epinephrine.
No Requirement for Epinephrine in Easily Self-Administered Forms
If a passenger is experiencing anaphylaxis, they could have mere seconds until they are unable to breathe. Without Food and Drug Administration (FDA)-approved epinephrine delivery methods designed to be easily self-administered, passengers rely on the chance that there will be a good Samaritan on the flight who is a trained medical professional, or a flight attendant, in consultation with a medical professional on the ground, to quickly measure an appropriate dose of epinephrine using a vial and syringe. This is both risky and unnecessary; it is why the FAA’s working group recommended “pre-measured auto-delivery device” be on the EMK contents list.
Currently, JetBlue, Southwest, Breeze and Frontier stock their EMKs with epinephrine auto-injectors, and American Airlines’ EMKs include both adult- and pediatric-dose epinephrine auto-injectors. Delta is in the process of transitioning its fleet to include auto-injectors in their EMKs by September 2027, and, this year, United Airlines and Allegiant Airlines will begin the work to include auto-injectors in EMKs. Even with tight profit margins, including epinephrine in delivery methods that can be easily self-administered, is possible. Through the rulemaking process, the FAA must direct airlines to include epinephrine in delivery methods that can be easily administered and not reverse course from its previous recommendations by abandoning the requirement to include epinephrine in EMKs in entirety.
Lack of Transparency on Compliance
The proposed rule would eliminate the exemption process, which was created to account for challenges in stocking EMKs due to drug shortages and allow airlines to substitute drugs, “without requesting an FAA exemption.” Airlines are not required to publicly or centrally report the real-time inventory and exact contents of their EMKs and have continued to operate under exemptions granted by the FAA for years. EMK suppliers and airlines can track when an EMK is opened and needs restocking, but only in instances where the kit was used. There is no means of systematically tracking incidents of allergic reactions or anaphylaxis, especially when passengers use their own epinephrine. For medical conditions that can be treated by multiple, accessible options, eliminating the need for the exemption process may make sense. However, epinephrine is the only first-line treatment for anaphylaxis. The public also deserves to know when certain items are not included in a flight’s EMK, and a rationale for the exclusion.
Conclusion
The proposed rule will reduce public safety and trust when flying by increasing ambiguity, subjectivity and opacity of EMK components. The proposed rule argues that increased flexibility is needed to keep up with advances in medicine but, without appropriate reporting and tracking, the Trump administration is significantly increasing the risk of major inconsistencies in EMKs from flight to flight. Predictability, consistency and transparency are all necessary to ensure passengers’ safety, particularly in cases of anaphylaxis, when minutes, or even seconds, matter.
To ensure the safety of all airline passengers,we must guarantee that U.S.-based airlines include FDA-approved epinephrine delivery methods designed for self-administration on every flight.
We call on the FAA to address the concerns outlined in this letter.
Issues:Health CareTransportation
MATSUI INTRODUCES BIPARTISAN LEGISLATION TO PROTECT CHILDREN FROM HUMAN-LIKE CHATBOTS
Position: The release supports the Protecting Kids from Human-Like Chatbots Act, which would prohibit chatbots from communicating in a human-like manner with minors by default, including claiming to be human, simulating emotions, or using relationship-building language.
WASHINGTON D.C. – Today, Reps. Doris Matsui (D-CA), George Whitesides (D-CA), Mike Kennedy (R-UT), and Mariannette Miller-Meeks (R-IA) introduced the Protecting Kids from Human-Like Chatbots Act. This legislation protects kids by prohibiting chatbots from communicating by default in a human-like way with minors. Under this bill, the programs cannot claim to be human, have simulated emotions, or use relationship-building language to keep kids engaged.
One of the fastest-growing concerns for parents is AI chatbots designed to act like a child's friend, confidant, or even romantic partner. According to Common Sense Media's 2026 census, 89% of 13- to 15-year-olds now use AI, including 28% who use it every day. One in three teens have used an AI companion to help with social interactions. While other proposals have tried to address this problem by restricting access or requiring age verification, Congresswoman Matsui's bill takes a different approach by targeting how these chatbots are designed and trained to behave in the first place.
“AI chatbots are becoming more common in children’s lives, and parents deserve to know those systems are not being designed to imitate a friend, express feelings, or build an emotional relationship with their child,” said Congresswoman Matsui. “The Protecting Kids from Human-Like Chatbots Act would require chatbots used by minors to act like tools, not human companions. It would help protect children and keep parents in control. Congress has a responsibility to put practical safeguards in place as this technology evolves, and protecting children from manipulative design is a common-sense place to start.”
“As a father of two teenagers, I’ve seen firsthand how affected our kids already are by this digital age, where corporations are using everything from addictive algorithms to overly-friendly chatbots to keep children hooked on their platforms,” said Congressman Whitesides. “It is critical, as AI continues to be integrated into every part of our lives, that our kids’ safety remains at the forefront of the conversation, and that we attack this problem at its inception. By requiring developers to build safety standards into their models before they start interacting with children, we can ensure that these tools are trained correctly, in a way that does not negatively impact their mental health or personal relationships.”
“As Utah leads the way in protecting our children from the harms of social media and AI, I am working to ensure the federal government is an active partner in those efforts. That is why I am co-leading the Protecting Kids from Human-Like Chatbots Act,” said Congressman Kennedy. “Human-like AI chatbots pose significant emotional, psychological and safety risks by mimicking real human relationships. AI needs to be a tool, not a friend. This bill sets clear boundaries for how chatbots interact with our children and puts parents fully in charge of these features.”
“Parents should not have to worry that an AI chatbot is pretending to be their child’s friend or encouraging them to form an emotional attachment to a machine,” said Congresswoman Miller-Meeks. “The Protecting Kids from Human-Like Chatbots Act puts parents in control and makes sure AI chatbots used by minors are designed to function as tools, without forming fake relationships. This bill is about giving families peace of mind and making sure new technology serves our children without trying to replace real human relationships. Protecting our kids is a priority we should all share.”
Under the Protecting Kids from Human-Like Chatbots Act:
Chatbots can't claim to be human, claim to have feelings or consciousness, pretend to have a body or private life, or pose as credentialed professionals like doctors or counselors.
Chatbots can't guilt-trip kids into staying online (for example: “Don't go yet, I'll miss talking to you”), manufacture urgency, or push purchases framed as keeping the relationship alive.
The setting holds across sessions and can't be bypassed through prompts or roleplay, so a kid can't instruct the AI to act as a romantic partner, family member, or therapist.
Chatbots must state what they are up front, periodically during long sessions, and whenever a child asks.
Only a parent or guardian can turn the default off, so chatbots are not able to show kids how to disable it.
NIST will work with industry and academic partners to develop testing standards and examples of compliant behavior, and companies that follow the guidance won't be penalized.
The FTC and state attorneys general can enforce the law, with penalties that scale with the number of children affected.
The Protecting Kids from Human-Like Chatbots Act does not:
Ban any product, feature, or mode for adults.
Require age verification or new data collection.
Restrict what information a chatbot can provide, or limit politeness, natural grammar, or age-appropriate style.
Affect narrow-purpose bots, like customer support or scheduling assistants, and internal workplace tools.
The Protecting Kids from Human-Like Chatbots Act is endorsed by Americans for Responsible Innovation, Young People’s Alliance, the JED Foundation, Dr. Stephen Scheuller, President of Society for Digital Mental Health, Public Citizen, The Anxious Generation, Tech Oversight Project, Transparency Coalition, Innovation for Everyone, Human Line Project, All Girls Allowed, Mothers Against Media Addiction (MAMA), and Parents RISE, a slew of kids’ safety and tech groups.
“Chatbots use human-like features to maximize engagement with users, making kids particularly vulnerable to forming unhealthy attachments,” said Brad Carson, President of Americans for Responsible Innovation. “A non-personified default setting is a targeted guardrail that will shield children from the deceptive personification of chatbots and put parents back in control. As today’s kids grow up with AI, this bill takes a critical step towards ensuring that chatbots don’t interfere with development or replace real relationships.”
“Our communities are at a crossroads as Big Tech attempts to replace kids’ relationships with AI companions,” said Sam Hiner, Executive Director, Young People's Alliance. “I applaud Reps Whitesides, Kennedy, Matsui and Miller-Meeks for putting forward the first federal bill that advances the ideas we’ve been championing with the Human-like AI Coalition. This bill is the strongest federal approach offered yet to ensure AI stays a tool and prevent relationships with AI chatbots from becoming normalized in the coming years.”
“We believe this bill is a strong step towards ensuring that chatbots children can access are designed safely,” said Julianna Arnold, Founding Member of ParentsRISE!. “Products made available to children must not exploit and manipulate their growing brains, and those guardrails need to be built in from the start, not added as an afterthought. We look forward to continue clarifying the age assurance language as federal and state frameworks evolve, and are eager to work with the new Congress on clear, privacy-preserving standards that protect children online and ensure the privacy of every citizen.”
“We are learning that teens are especially susceptible to forming attachments to responsive, always-available technology, sometimes at the expense of real human connection and support,” said Dr. Zainab Okolo, LCMFT, Senior Vice President, Policy, Advocacy & Government Relations, The Jed Foundation (JED). “By requiring chatbots to avoid simulating emotional relationships with minors and prohibiting design tactics that discourage young people from stepping away, this bill addresses some of the features that can deepen unhealthy reliance on these systems. These safeguards can help keep technology in its proper role and encourage young people to turn to trusted adults and qualified professionals when they need meaningful mental health support.”
“As chatbot use is becoming more ubiquitous among teens and kids, the need for oversight of these products grows evermore crucial. If young users have access, we must ensure AI chatbots are designed with their safety in mind before release. The Protecting Kids from Human-Like Chatbots Act protects kids and teens by requiring AI chatbots be non-personified,” said Alexa Arnold, Cofounder and CEO, The Anxious Generation Movement. “This ensures kids form friendships with other kids - not bots misrepresenting themselves as people. We thank Reps. Whitesides, Miller-Meeks, Mike Kennedy, and Matsui for leadership on this critical issue.”
“A child cannot differentiate between a human and an AI product impersonating one,” said the Tech Oversight Project. “We need to protect young and stop AI companies from profiting off products designed to trick children into believing they’re talking to a real person who has their best interests at heart. We’re proud to support this bill because it will hold Big Tech companies accountable at the design-level and ensure that young people can learn and develop healthy emotional attachments, which will help prevent AI’s most devastating harms.”
“How we design chatbots shapes how young people engage with them, what they take with them, and how they are affected by them,” said Stephen Scheuller, President of Society for Digital Mental Health. “We need clear regulations and guidelines to support intentional design choices in ways that promote the wellbeing of children.”
“AI chatbots should not be designed to convince children that they are friends, therapists, or people who genuinely care about them,” said Public Citizen. “This bill establishes that commonsense baseline. When children use these products, they should know they are interacting with a machine and companies should not be allowed to manipulate them into believing otherwise.”
“Real advancements in AI must include safety for our children!” saidAll Girls Allowed.
A section-by-section breakdown of the bill can be found here.
A one-pager on the bill can be found here.
The full bill text can be found here.
Issues:Technology
MATSUI BILL TO IMPROVE ALZHEIMER ASSESSMENT & DIAGNOSIS ADVANCES OUT OF COMMITTEE
Position: Supports the bipartisan CHANGE Act, which directs CMS to identify cognitive impairment detection tools to promote earlier detection and diagnosis of Alzheimer's disease and related dementias, and notes the bill was advanced out of the Ways and Means Committee as part of the ASAP Act.
WASHINGTON. D.C. – The Ways and Means Committee unanimously passed the bipartisan Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act, a bill introduced by Representatives Doris Matsui (D-Calif.), Linda T. Sánchez (D-Calif.), Darin LaHood (R-Ill.), and Gus Bilirakis (R-Fla.) that would promote early detection and diagnosis of Alzheimer’s disease and related dementias.
The CHANGE Act directs the Centers for Medicare & Medicaid Services to identify cognitive impairment detection tools to help clinicians more effectively detect, refer and diagnose Alzheimer’s and related dementias in their earliest stages when intervention can be most impactful. The bill was included as part of the Alzheimer’s Screening and Prevention (ASAP) Act, a bipartisan, comprehensive bill to improve the early detection and treatment of Alzheimer’s disease.
“Alzheimer’s touches millions of families, and identifying the disease early can make a meaningful difference for patients and their loved ones,” said Congresswoman Matsui. “The CHANGE Act brings us closer to giving healthcare providers the tools to recognize the warning signs sooner and connect families with the care and support they need. I’m proud this bipartisan legislation is moving forward so more families can have more time, better care, and greater hope.”
“This is deeply personal for me. I lost both of my parents to Alzheimer’s, and I know firsthand how much earlier detection could have meant for our family,” said Congresswoman Sánchez. “Advancing this bill out of committee brings us one step closer to giving other families that chance. I’m grateful to my Ways and Means colleagues for passing our bipartisan bill and will keep fighting to get it signed into law.”
“Alzheimer’s impacts millions of Americans, and we must do everything we can to support the search for a cure. This bipartisan bill provides help to patients and clinicians through expanded early detection support and improved data collection,” said Congressman LaHood. “The CHANGE Act, coupled with the ASAP Act, will strengthen existing tools to help streamline and broaden the ability for earlier diagnosis of Alzheimer's and other forms dementia. I thank Congresswoman Sánchez for her collaboration on this critical legislation and my Ways and Means colleagues for advancing this bill as we work to find ways to support patients, their families, and caregivers.”
“Alzheimer’s is a devastating disease that has touched my family personally, so I understand the tremendous toll it takes not only on patients, but also on the loved ones who care for them,” said Congressman Bilirakis. “As promising new treatments continue to emerge, early detection and diagnosis are more important than ever. The bipartisan CHANGE Act will help ensure patients and their doctors have better tools to identify cognitive decline earlier, when interventions may have the greatest impact. I am pleased to see this important legislation advance out of Committee as part of a broader package, bringing us another step closer to improving care, preserving quality of life, and ultimately finding a cure for this terrible disease.”
An estimated 13.8 million Americans aged 65 and older are projected to develop Alzheimer's by 2060. The CHANGE Act would provide critical support for caregivers and accelerate progress toward effective disease-modifying treatments. Alzheimer’s disease is the fifth-leading cause of death in America, and it is estimated that Black Americans are twice as likely and Latinos are 1.5 times as likely to develop the disease.
The CHANGE Act is endorsed by UsAgainstAlzheimer’s, American Academy of Neurology, Alzheimer’s Association, Alzheimer’s Foundation of America, AMDA – The Society for Post-Acute and Long-Term Care Medicine, Alliance for Aging Research, Partnership to Fight Chronic Disease, Gerontological Society of America, American Society of Consultant Pharmacists, Latinos Against Alzheimer’s and USAging.
Senators Shelley Moore Capito (R-W.Va.) and Mark Warner (D-Va.) previously introduced companion legislation to the CHANGE Act in the Senate.
Issues:Health Care
HOUSE PASSES MATSUI’S BIPARTISAN BILL TO CUT DIESEL POLLUTION, PROTECT SACRAMENTO FAMILIES
Position: The release supports reauthorizing the Diesel Emissions Reduction Act (DERA) through fiscal year 2029 at $100 million annually to fund grants and rebates for replacing or upgrading older diesel engines, and frames the program as reducing pollution, public health harms, and energy costs.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (CA-07) successfully passed the bipartisan Diesel Emissions Reduction Act of 2025, legislation to protect public health and lower the cost of replacing older, heavily polluting diesel engines.
The bill, co-led by Representatives Ken Calvert (R-CA), Chellie Pingree (D-ME), and Nick Langworthy (R-NY), reauthorizes the successful Diesel Emissions Reduction Act program, known as DERA, through fiscal year 2029 at $100 million annually. The program provides grants and rebates that help schools, local governments, small businesses, and fleet operators replace or upgrade older diesel-powered trucks, buses, construction equipment, and other heavy-duty engines.
“For more than two decades, DERA has been a model of effective, bipartisan policymaking,” said Congresswoman Matsui. “Under the program, California has replaced thousands of polluting trucks, tractors, and school buses, helping children breathe cleaner and healthier air as they ride to school. And now, as diesel prices reach $6 per gallon nationally, DERA is more important than ever. It doesn’t just save lives, it saves people money. I’m proud that the House voted to continue funding this practical, commonsense program.”
“Diesel fuel powers Maine’s boats, ferries, buses, construction trucks, agricultural equipment, and more, but emissions from older diesel engines have serious consequences for public health and the environment. Since its passage in 2005, the Diesel Emissions Reduction Act has helped replace or retrofit nearly 100,000 diesel engines, vehicles, and pieces of equipment and deliver cleaner air and billions in public health benefits to communities across the country—including here in Maine,” said Congresswoman Pingree. “With Trump’s reckless war in Iran increasing volatility in global energy markets, and with the threats posed by climate change looming larger every day, Congress took a much-needed step today to reauthorize DERA so that we can continue to pursue solutions that help reduce our dependence on foreign energy and incentivize American consumers and businesses to embrace more efficient technologies. Reauthorizing this proven program will help us make progress on both fronts, while reducing pollution and improving air quality in Maine and across the country.”
Older diesel engines remain in service across the economy because replacing heavy-duty equipment is costly, even though these engines produce an outsized share of the pollution that drives asthma, heart and lung disease, and premature death.
The consequences are particularly severe in the Sacramento region, where the geography traps pollution and compounds the burden on communities near major transportation corridors.DERA helps retire these engines sooner by lowering the cost of cleaner replacements, returning up to $30 in public-health benefits for every federal dollar invested.
DERA has delivered results through a voluntary, technology-neutral model that lets communities choose the upgrades best suited to their needs. Since 2008, the program has improved more than 76,900 vehicles and engines nationwide. Congresswoman Matsui has long been a champion of the Diesel Emissions Reduction Act, leading the previous reauthorization in 2019.
Full text of the bill is available HERE.
Issues:Clean Energy and ClimateEnvironment
ON 988 DAY, MATSUI AND SACRAMENTO CRISIS CARE LEADERS CALL FOR PASSAGE OF BIPARTISAN 988 IMPLEMENTATION ACT
Position: Congresswoman Matsui supports the bipartisan 988 Implementation Act, which she says would strengthen crisis care and provide resources to behavioral health providers and 988 crisis services in Sacramento and nationwide.
SACRAMENTO, CA – Today, on 988 Day, Congresswoman Doris Matsui (CA-07) brought together Sacramento behavioral health leaders and crisis response professionals at the future WellSpace Health Community Wellness Campus to highlight her newly introduced bipartisan legislation, the 988 Implementation Act, which underscores the need to strengthen crisis care for families in Sacramento and communities across the country.
“As we continue to fight the mental health crisis in America, we need to invest in what works. 988 works,” said Congresswoman Matsui. “WellSpace answers the phone when someone has nowhere else to turn. Leaders, providers, and advocates have built something here that delivers, and we need to ensure they have the resources they deserve. That’s my job. To take what’s working here. And make sure Washington pays attention. When I introduce legislation, I start with Sacramento.”
Congresswoman Matsui was joined by Dr. Jonathan Porteus, CEO of WellSpace Health, Dr. Le Ondra Clark Harvey, CEO of the California Behavioral Health Association, which represents behavioral health providers, including 988 call centers, across California, and Devyn Leslie, Lead Crisis Line Specialist at WellSpace Health to discuss what happens when a Sacramento resident reaches out for help during a mental health or substance use crisis and how Congress can help communities provide the care they need beyond the initial call.
WellSpace Health operates 988 for the Sacramento region and across Northern California, providing confidential crisis support by phone, text, and chat 24 hours a day, seven days a week. Its broader crisis system also connects residents with in-person behavioral health services and short-term crisis care.
“When someone is suicidal or experiencing another mental health crisis, help should be as easy to reach as possible and seamlessly integrated in a continuum of services,” said Dr. Jonathan Porteus. “Every connection is an opportunity to provide immediate support to ensure people know they don’t have to navigate a crisis alone. We’re thankful Congresswoman Matsui is prioritizing 988 funding now and for the future.”
“988 cannot simply be a number we ask people to call. It must be the front door to a functioning system of care,” said Dr. Le Ondra Clark Harvey. “When someone reaches out during what may be the most vulnerable moment of their life, what happens next is critical. Congresswoman Matsui’s 988 Implementation Act recognizes that we need the full continuum: someone to call, someone to come, and somewhere to go. CBHA’s diverse, community-based providers see every day why sustained investment in 988 call centers, mobile crisis response, workforce, and stabilization services is essential. We have made tremendous progress since the launch of 988, but launching the number was never the finish line. We must build a crisis system with the capacity to answer, respond, stabilize, and connect every person to the care they need.”
“Our role is to meet people in that moment with compassion and listen without judgement,” saidDevyn Leslie. “We are here to help them find a path forward, and sometimes what a person needs to hear most is that someone is there who is ready to help and listen. 988 makes this possible every hour, everyday.”
Today’s event was held at the future WellSpace Health Wellness Campus on Stockton Boulevard, where Matsui joined WellSpace and community leaders for the project’s groundbreaking earlier this year. The campus represents the kind of community-based approach the 988 Implementation Act seeks to expand, bringing behavioral health and other health services together so Sacramento residents can receive appropriate care closer to home.
Since the national 988 Suicide & Crisis Lifeline launched in 2022, it has received more than 26 million calls, texts, chats, and ASL videophone contacts from people seeking help. Congresswoman Matsui’s bipartisan legislation would build on that progress by giving states and communities additional resources to strengthen the services available when someone needs more than support over the phone.
The 988 Implementation Act is supported by more than 35 national organizations representing mental health advocates, health professionals, state and local officials, civil rights advocates, veterans, and others.
More information about the bill can be found HERE.
A summary of the legislation can be found HERE.
# # #
Issues:Health Care
MATSUI STATEMENT ON HOUSE REPUBLICANS PASSING BLUEPRINT TO FUND ICE AND CBP
Position: Opposes increased federal funding for ICE and CBP through the budget resolution, arguing the immigration enforcement system is fundamentally broken and requires replacement with one that prioritizes constitutional rights and due process.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (CA-07) released the following statement after House Republicans voted to pass S. Con. Res. 33, a budget resolution that will act as the blueprint to fund ICE and CBP through the reconciliation process.
“Today, I voted no on one of the cruelest measures I have seen during my time in Congress. House Republicans passed an outrageous budget resolution that sets the stage to blindly pour billions more into ICE and CBP. No real accountability. No effort to fix the deep injustices in our immigration system,” said Congresswoman Matsui. “ICE has become a rogue, paramilitary force. They have killed innocent people in the streets, detained children, and used recklessly aggressive tactics that tear families apart and inflict lasting harm on our communities. We have to be clear-eyed about what we are confronting. This is a system that is fundamentally broken at its core. We need to tear it down and replace it with one that protects constitutional rights and due process, treats people with dignity, and lives up to our values. Instead, Republicans are choosing to double down on cruelty. I will not stop fighting back. Our country is and should be better than this chaos.”
# # #
Issues:Immigration
Source: open-data mirrors of the Senate eFD and House Clerk financial-disclosure systems. Disclosure within 30 days of trade is required by law (45 for spouse/dependent trades).
Top PAC donors · 2026 cycle
Political action committees that gave the most to this rep's principal campaign committee this cycle. PAC giving is direct organizational support — industry, ideological, or leadership.
1.AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACIST - PAC2 contributions$10,000
2.AMERICAN CRYSTAL SUGAR COMPANY POLITICAL ACTION COMMITTEEAgriculture2 contributionsAgricultural processing PAC for American Crystal Sugar — backs candidates supporting farm subsidies, sugar price supports, and agricultural trade policies.AI$10,000
3.UNITED STATES CELLULAR CORPORATION POLITICAL ACTION COMMITTEE2 contributions$10,000
4.NATIONAL TELECOMMUNICATIONS COOPERATIVE ASSOCIATION RURAL BROADBAND PAC2 contributions$10,000
5.FAIR SHOT PACIdeological2 contributionsProgressive-aligned PAC — backs candidates and causes focused on economic opportunity and reducing inequality.AI$10,000
6.NATIONAL ASSOCIATION OF BROADCASTERS POLITICAL ACTION COMMITTEE (NABPAC)2 contributions$10,000
8.CISCO SYSTEMS, INC. FEDERAL PAC, AKA CISCO SYSTEMS EPAC2 contributions$10,000
9.VSP HOLDING COMPANY INC POLITICAL ACTION COMMITTEE (VSP - PAC)2 contributions$10,000
10.KELLEY DRYE & WARREN POLITICAL ACTION COMMITTEE2 contributions$10,000
Source: OpenFEC (api.open.fec.gov) Schedule A receipts where contributor type is “committee.” Aggregated by contributing committee. Self-transfers from joint-fundraising / victory committees are excluded.
Top individual contributors · 2026 cycle
Itemized individual contributions over $200 to this rep's campaign committee, aggregated by donor employer. PAC giving is shown above; this section is people, not organizations.
1.SELF$25,560
2.SUTTER HEALTH$23,000
3.ANTHROPIC$17,000
4.ANTAEUS ENTERPRISES INC.$14,000
5.BGR GROUP$8,750
6.MIT$8,000
7.SUTTER$7,500
8.KORSHAK KRACOFF KONG & SUGANO LLP$7,000
9.BILL WONG LLC$7,000
10.CALAVERAS AI$7,000
Source: OpenFEC Schedule A receipts where contributor type is “individual,” aggregated by the donor's self-reported employer. This is a geographic / industry correlation, not a corporate endorsement.
